Reports of Patent, Design, and Trade Mark Cases, Issues 1-5; Issues 8-13Published at the Patent Office Sales Branch, 2003 - Industrial property |
From inside the book
Results 1-3 of 27
Page 49
... gene will influence whether it expresses , and , if so to what extent , just as with a naturally occurring gene . By 1983 , it was known that the level of protein expression depended on the number of copies of the relevant gene present ...
... gene will influence whether it expresses , and , if so to what extent , just as with a naturally occurring gene . By 1983 , it was known that the level of protein expression depended on the number of copies of the relevant gene present ...
Page 58
... gene ( like almost any other gene ) is ' switched off ' by a negative regulatory element ( ' NRE ' ) . TKT introduce into the genome of a human cell , upstream of the EPO gene disclosed in Table VI of 605 , a nucleotide sequence which ...
... gene ( like almost any other gene ) is ' switched off ' by a negative regulatory element ( ' NRE ' ) . TKT introduce into the genome of a human cell , upstream of the EPO gene disclosed in Table VI of 605 , a nucleotide sequence which ...
Page 59
... gene , and , because of its proximity thereto , the EPO gene will similarly multiply ( again , this is described in the 605 patent , in Example 10 ) . The normal type of cell used in this procedure was the DuX - B11 CHO cells , also ...
... gene , and , because of its proximity thereto , the EPO gene will similarly multiply ( again , this is described in the 605 patent , in Example 10 ) . The normal type of cell used in this procedure was the DuX - B11 CHO cells , also ...
Other editions - View all
Common terms and phrases
ALBERTA FERRETTI amendment Amgen amino acid Appointed Person Arsenal FC Arsenal Football Club burner cell claim 19 claimant colour common general knowledge contact lens CooperVision Court of Appeal cross-examination Davies decision defendants Directive distinctive character DNA sequence dots earlier trade mark effect erythropoietin European Patent evidence filed gene hearing officer High Court Inc v Transkaryotic infringement Integer inventive step iris section issue judge judgment Kirin-Amgen Inc lenses likelihood of confusion Ltd's Trade Mark Marks Act 1994 Meneghetti non-use opponent paragraph numbers paras Patent Office Philips Electronics NV Plc v Reed prior art priority date protein question Quickfit reason Reed Business Information referred registered trade mark registrar relation relevant Remington Consumer Products revocation shape Silverleaf specification submissions Sweet & Maxwell Synthon third party TORRES TRADE MARK 2003 Trade Mark Application trade mark proprietor Trade Marks Act Transkaryotic Therapies Inc uEPO United Kingdom word